Chain Weight Reduction, Strength Enhancement and Improved Environmental Resistance, and Customer-Responsive R&D
First written in FY2016. 28 of 33 entries say "Restated". Latest entry: FY2026.
4 other companies' latest entry also says "Other".
- FY2026Disclosure of ¥12.644 million in research and development expensesAnnual report
「Research and development expenses related to these activities amounted to ¥12.644 million.」
The company continues development aimed at reducing chain weight, improving fatigue strength and enhancing environmental resistance, as well as meeting customer requirements for metal injection molded products, and disclosed ¥12.644 million in research and development expenses. - FY2026-H1RestatedAnnual report
「Research and development activities across the group during the interim consolidated accounting period amounted to ¥5 million. There were no material changes in the status of the group's research and development activities during the interim consolidated accounting period.」
The company stated that there were no material changes in its research and development activities and disclosed research and development expenses of ¥5 million for the interim consolidated accounting period. - FY2025Disclosure of ¥9.269 million in research and development expensesAnnual report
「In our group's core chain business, we continue to conduct research aimed at reducing weight, improving fatigue strength and enhancing environmental resistance. In our metal injection molding business, we continue development to meet customer requirements. Research and development expenses related to these activities amounted to ¥9.269 million.」
The company continues development aimed at reducing chain weight, improving strength and environmental resistance, and meeting customer requirements for metal injection molded products, and disclosed ¥9.269 million in research and development expenses. - FY2024Disclosure of ¥8.978 million in research and development expensesAnnual report
「In our core chain business, we continue to conduct research aimed at reducing weight, improving fatigue strength and enhancing environmental resistance. In our metal injection molding business, we continue development to meet customer requirements. Research and development expenses related to these activities amounted to ¥8.978 million.」
The company continues research into reducing chain weight, improving strength and environmental resistance, and meeting customer requirements for metal injection molded products, and recognized ¥8.978 million in research and development expenses. - FY2024-Q2RestatedAnnual report
「Research and development activities during the cumulative second quarter amounted to ¥4 million. There were no material changes in the status of the company's research and development activities during the cumulative second quarter.」
The company reconfirmed that there were no material changes in its research and development activities and disclosed research and development expenses of ¥4 million for the cumulative second quarter. - FY2024-Q1RestatedAnnual report
「Research and development activities during the cumulative first quarter amounted to ¥1 million. There were no material changes in the status of the company's research and development activities during the cumulative first quarter.」
The company reconfirmed that there were no material changes in its research and development activities and disclosed research and development expenses of ¥1 million for the quarter. - FY2023-Q3RestatedAnnual report
「Research and development activities during the cumulative third quarter amounted to ¥5 million. There were no material changes in the status of the company's research and development activities during the cumulative third quarter.」
The company recognized ¥5 million in research and development expenses and reconfirmed that there were no material changes in its research and development activities. - FY2023-Q2RestatedAnnual report
「Research and development activities during the cumulative second quarter amounted to ¥3 million. There were no material changes in the status of the company's research and development activities during the cumulative second quarter.」
The company recognized ¥3 million in research and development expenses and stated that there were no material changes in its research and development activities. - FY2023-Q1RestatedAnnual report
「Research and development activities during the cumulative first quarter amounted to ¥1 million. There were no material changes in the status of the company's research and development activities during the cumulative first quarter.」
The company reconfirmed that there were no material changes in its research and development activities and disclosed research and development expenses of ¥1 million for the quarter. - FY2022Disclosure of ¥10.602 million in research and development expensesAnnual report
「In our core chain business, we continue to conduct research aimed at reducing weight, improving fatigue strength and enhancing environmental resistance. In our metal injection molding business, we continue development to meet customer requirements. Research and development expenses related to these activities amounted to ¥10.602 million.」
The company continues research and development aimed at improving chain performance and meeting customer requirements for metal injection molded products, and recognized ¥10.602 million in research and development expenses. - FY2022-Q3RestatedAnnual report
「Research and development activities during the cumulative third quarter amounted to ¥8 million. There were no material changes in the status of the company's research and development activities during the cumulative third quarter.」
The company recognized ¥8 million in research and development expenses and stated that there were no material changes in research and development activities related to chains and metal injection molding. - FY2022-Q2RestatedAnnual report
「Research and development activities during the cumulative second quarter amounted to ¥4 million. There were no material changes in the status of the company's research and development activities during the cumulative second quarter.」
The company recognized ¥4 million in research and development expenses and stated that there were no material changes in its research and development activities. - FY2022-Q1RestatedAnnual report
「Research and development activities during the cumulative first quarter amounted to ¥2 million. There were no material changes in the status of the company's research and development activities during the cumulative first quarter.」
The company recognized ¥2 million in research and development expenses and reconfirmed that there were no material changes in research and development activities related to chains and metal injection molding. - FY2021RestatedAnnual report
「In our core chain business, we continue to conduct research aimed at reducing weight, improving fatigue strength and enhancing environmental resistance. In our metal injection molding business, we continue development to meet customer requirements. Research and development expenses related to these activities amounted to ¥12.808 million.」
The company continues research and development aimed at reducing chain weight, improving strength and environmental resistance, and meeting customer requirements in metal injection molding, and recognized ¥12.808 million in research and development expenses. - FY2021-Q3RestatedAnnual report
「Research and development activities during the cumulative third quarter amounted to ¥9 million. There were no material changes in the status of the company's research and development activities during the cumulative third quarter.」
The company recognized ¥9 million in research and development expenses and stated that there were no material changes in its research and development activities. - FY2021-Q2RestatedAnnual report
「Research and development activities during the cumulative second quarter amounted to ¥5 million. There were no material changes in the status of the company's research and development activities during the cumulative second quarter.」
The company recognized ¥5 million in research and development expenses and stated that there were no material changes in its research and development activities. - FY2021-Q1RestatedAnnual report
「Research and development activities during the cumulative first quarter amounted to ¥2 million. There were no material changes in the status of the company's research and development activities during the cumulative first quarter.」
The company recognized ¥2 million in research and development expenses and stated that there were no material changes in its research and development activities. - FY2020-Q3RestatedAnnual report
「Research and development activities during the cumulative third quarter amounted to ¥10 million. There were no material changes in the status of the company's research and development activities during the cumulative third quarter.」
The company recognized ¥10 million in research and development expenses and reconfirmed that there were no material changes in research and development activities related to chains and metal injection molding. - FY2020-Q2RestatedAnnual report
「Research and development activities during the cumulative second quarter amounted to ¥7 million. There were no material changes in the status of the company's research and development activities during the cumulative second quarter.」
The company recognized ¥7 million in research and development expenses and reconfirmed that there were no material changes in research and development activities related to chains and metal injection molding. - FY2020-Q1RestatedAnnual report
「Research and development activities during the cumulative first quarter amounted to ¥3 million. There were no material changes in the status of the company's research and development activities during the cumulative first quarter.」
The company recognized ¥3 million in research and development expenses and reconfirmed that there were no material changes in its research and development activities. - FY2019RestatedAnnual report
「In our core chain business, we continue to conduct research aimed at reducing weight, improving fatigue strength and enhancing environmental resistance. In our metal injection molding business, we continue development to meet customer requirements. Research and development expenses related to these activities amounted to ¥13.954 million.」
The company continues research and development aimed at reducing chain weight, improving strength and environmental resistance, and meeting customer requirements in metal injection molding, and recognized ¥13.954 million in research and development expenses. - FY2019-Q3RestatedAnnual report
「Research and development activities during the cumulative third quarter amounted to ¥11 million. There were no material changes in the status of the company's research and development activities during the cumulative third quarter.」
The company recognized ¥11 million in research and development expenses and reconfirmed that there were no material changes in its research and development activities. - FY2019-Q2RestatedAnnual report
「Research and development activities during the cumulative second quarter amounted to ¥7 million. There were no material changes in the status of the company's research and development activities during the cumulative second quarter.」
The company recognized ¥7 million in research and development expenses and reconfirmed that there were no material changes in research and development activities related to chains and metal injection molding. - FY2019-Q1RestatedAnnual report
「Research and development activities during the cumulative first quarter amounted to ¥3 million. There were no material changes in the status of the company's research and development activities during the cumulative first quarter.」
The company recognized ¥3 million in research and development expenses and reconfirmed that there were no material changes in its research and development activities. - FY2018RestatedAnnual report
「In our core chain business, we continue to conduct research aimed at reducing weight, improving fatigue strength and enhancing environmental resistance. In our metal injection molding business, we continue to conduct research to meet customer requirements. Research and development expenses related to these activities amounted to ¥16.536 million.」
The company continues research and development aimed at reducing chain weight, improving strength and environmental resistance, and meeting customer requirements for metal injection molded products, and recognized ¥16.536 million in research and development expenses. - FY2018-Q3RestatedAnnual report
「Research and development activities during the cumulative third quarter amounted to ¥13 million. There were no material changes in the status of the company's research and development activities during the cumulative third quarter.」
The company recognized ¥13 million in research and development expenses and reconfirmed that there were no material changes in research and development activities related to chains and metal injection molding. - FY2018-Q2RestatedAnnual report
「Research and development activities totaled ¥9 million during the cumulative second-quarter period. There was no material change in the status of the company's research and development activities during the cumulative second-quarter period.」
The company recognized ¥9 million in research and development expenses and reconfirmed that there were no material changes in research and development activities related to chains and metal injection molding. - FY2018-Q1RestatedAnnual report
「Research and development activities during the cumulative first quarter amounted to ¥5 million. There were no material changes in the status of the company's research and development activities during the cumulative first quarter.」
The company recognized ¥5 million in research and development expenses and stated that there were no material changes in its research and development activities. - FY2017RestatedAnnual report
「In our core chain business, we continue to conduct research aimed at reducing weight, improving fatigue strength and enhancing environmental resistance. In our metal injection molding business, we continue to conduct research to meet customer requirements. Research and development expenses related to these activities amounted to ¥15.269 million.」
The company continues research and development aimed at reducing chain weight, improving strength and environmental resistance, and meeting customer requirements for metal injection molded products, and recognized ¥15.269 million in research and development expenses. - FY2017-Q3RestatedAnnual report
「Research and development activities during the cumulative third quarter amounted to ¥12 million. There were no material changes in the status of the company's research and development activities during the cumulative third quarter.」
The company recognized ¥12 million in research and development expenses and stated that there were no material changes in its research and development activities. - FY2017-Q2RestatedAnnual report
「Research and development activities during the cumulative second quarter amounted to ¥8 million. There were no material changes in the status of the company's research and development activities during the cumulative second quarter.」
The company recognized ¥8 million in research and development expenses and stated that there were no material changes in its research and development activities. - FY2017-Q1RestatedAnnual report
「There were no material changes in the status of the Company’s R&D activities during the cumulative first-quarter period.」
The Group explicitly states that there were no material changes in its research and development activities. - FY2016First statedAnnual report
「In our core chain business, we continue to conduct research aimed at reducing weight, improving fatigue strength and enhancing environmental resistance. In our metal injection molding business, we continue to conduct research to meet customer requirements.」
The company continues to focus its research and development on improving chain performance and meeting customer requirements for metal injection molded products.